No Settlement In Sight In Perrigo's $163M Tax Row With U.S.
The U.S. government and Irish-registered generic pharmaceutical maker Perrigo Co. have failed to resolve a $163.4 million tax dispute during a settlement conference, according to minutes of the proceeding in a...To view the full article, register now.
Already a subscriber? Click here to view full article